CTSOVSDCOY• 3 Months (Normalized)
CTSO vs DCOY (Cytosorbents Corporation vs Decoy Therapeutics Inc.)
Showing Closing Date Range from Jul 3 to Oct 1, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CTSO Performance $3.9
+806.98%
Cytosorbents Corporation
Normalized Baseline0.00%
DCOY Performance $1.97
-72.83%
Decoy Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin CTSO LEADS
+879.81 pts
CTSO outperforming by 879.81 percentage points
CTSODCOY
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CTSO DCOY
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | CTSO Price | CTSO Gain (%) | DCOY Price | DCOY Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 30, 2026 | $3.90 | +806.98% | $1.97 | -72.83% | +879.81% |
| Sep 29, 2026 | $4.00 | +830.23% | $2.13 | -70.62% | +900.85% |
| Sep 28, 2026 | $4.02 | +834.88% | $2.31 | -68.14% | +903.02% |
| Sep 25, 2026 | $4.38 | +918.60% | $3.09 | -57.38% | +975.98% |
| Sep 24, 2026 | $4.30 | +900.00% | $3.11 | -57.10% | +957.10% |
| Sep 23, 2026 | $4.91 | +1041.86% | $3.85 | -46.90% | +1088.76% |
| Sep 22, 2026 | $- | $3.10 | -57.24% | - | |
| Sep 21, 2026 | $5.51 | +1181.40% | $2.56 | -64.69% | +1246.09% |
| Sep 18, 2026 | $5.75 | +1237.21% | $2.78 | -61.66% | +1298.87% |
| Sep 17, 2026 | $5.76 | +1239.53% | $2.83 | -60.97% | +1300.50% |
| Sep 16, 2026 | $5.73 | +1232.56% | $2.89 | -60.14% | +1292.70% |
| Sep 15, 2026 | $6.06 | +1309.30% | $2.71 | -62.62% | +1371.92% |
| Sep 14, 2026 | $6.07 | +1311.63% | $2.71 | -62.62% | +1374.25% |
| Sep 11, 2026 | $6.41 | +1390.70% | $2.67 | -63.17% | +1453.87% |
| Sep 10, 2026 | $6.37 | +1381.40% | $2.73 | -62.34% | +1443.74% |
Page 1 of 5